Results 291 to 300 of about 592,769 (337)

Prognostic Impact of Spontaneous Conversion to Sinus Rhythm in Patients With Symptomatic Paroxysmal Atrial Fibrillation: A Propensity‐Matched Follow‐Up Study

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Paroxysmal atrial fibrillation (PAF) patients do not invariably progress to persistent AF, with a consistent group of patients showing AF regression during follow‐up. The prognostic implications of spontaneous conversion (SCV) to sinus rhythm (SR) in those patients has never been evaluated yet.
Marco Valerio Mariani   +14 more
wiley   +1 more source

DilateD carDiomyopathy

open access: bronze, 2012
Ленар Фарахутдинович Сабиров   +4 more
openalex   +1 more source

Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All‐Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Obstructive sleep apnea (OSA) is a common risk factor for the development and progression of atrial fibrillation (AF). Whether catheter ablation for AF management in patients with coexisting OSA yields survival benefit remains unclear.
Ghassan Bidaoui   +16 more
wiley   +1 more source

USP10 in Neurological Disorders: Mechanistic Insights and Emerging Therapeutic Strategies

open access: yesAnnals of the New York Academy of Sciences, EarlyView.
USP10 is a deubiquitinating enzyme that affects neurological diseases through multiple mechanisms, including the accumulation of toxic proteins, autophagy, and immune responses. In this review, we discuss the structure and characteristics of USP10 and summarize the role of USP10 in neurological disorders.
Celemuge   +5 more
wiley   +1 more source

Atrial Arrhythmias in Cardiac Sarcoidosis—Case Presentation and Systematic Review

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Sarcoidosis is a rare idiopathic, multiorgan disease with clinical cardiac involvement in approximately 5% of cases. Diagnosis and management of cardiac sarcoidosis (CS) have mainly focused on impaired LV function, ventricular arrhythmias, and atrio‐ventricular conduction disease.
Emily C. Hodkinson   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy